Sentinel Lymph Node Biopsy Clinical Trial
Official title:
Sentinel Lymph Node Biopsy After Nipple Sparing Mastectomy: Prospective Study
Sentinel Lymph Node Biopsy (SLNB) after nipple sparing mastectomy (NSM) is controversial. This study aims to investigate feasibility of SLNB with radioisotope method.
Status | Not yet recruiting |
Enrollment | 20 |
Est. completion date | June 2020 |
Est. primary completion date | April 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years to 70 Years |
Eligibility |
Inclusion Criteria: NSM with/without SLNB at least 6 months prior to this study - Exclusion Criteria: previous axillary dissection and active breast cancer - |
Country | Name | City | State |
---|---|---|---|
Turkey | Acibadem Maslak Hospital | Istanbul | Sariyer |
Lead Sponsor | Collaborator |
---|---|
Acibadem University |
Turkey,
Intra M, Veronesi P, Gentilini OD, Trifirò G, Berrettini A, Cecilio R, Colleoni M, Rietjens M, Luini A, Paganelli G, Veronesi U. Sentinel lymph node biopsy is feasible even after total mastectomy. J Surg Oncol. 2007 Feb 1;95(2):175-9. — View Citation
Karam A, Stempel M, Cody HS 3rd, Port ER. Reoperative sentinel lymph node biopsy after previous mastectomy. J Am Coll Surg. 2008 Oct;207(4):543-8. doi: 10.1016/j.jamcollsurg.2008.06.139. Epub 2008 Jul 21. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Enhancement in axilla | Hot nodules will be showed in axilla after injection of SENTI-SCINT | 4 hours after injection |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03719833 -
Sentinel Lymph Node Biopsy After Neoadjuvant Treatment in Breast Cancer Patents
|
||
Recruiting |
NCT00654342 -
Comparison Between ex Vivo and in Vivo Injection of Blue Dye in Sentinel Lymph Node Mapping for Colon Cancer
|
N/A | |
Recruiting |
NCT01564264 -
Sentinel Node Biopsy in Endometrial Cancer
|
N/A | |
Recruiting |
NCT06212440 -
Clinical Application of Multi-modal Sentinel Lymph Node Staining Method in Breast Cancer Patients After Neoadjuvant Chemotherapy
|
N/A | |
Terminated |
NCT03630653 -
Sentinel Lymph Node Procedure in Ipsilateral Invasive Breast Cancer Relapse
|
N/A | |
Completed |
NCT03833960 -
SLNB After Neoadjuvant Treatment in Node Positive Patients
|
||
Active, not recruiting |
NCT04986306 -
The Validation of Sentinel Lymph Node Biopsy After Neo-adjuvant Chemotherapy in Breast Cancer Patients
|
||
Recruiting |
NCT05512468 -
Application of Preoperative Axillary Lymph Node Marking With Nano-Carbon in Breast Cancer Patients Before Neoadjuvant Chemotherapy
|
N/A | |
Recruiting |
NCT03199560 -
Tilmanocept vs Sulfur Colloid in Sentinel Lymph Node Biopsy
|
Phase 4 | |
Not yet recruiting |
NCT04932460 -
Contrast-enhanced Ultrasonography Combined With Blue Dye as Dual-tracer for Sentinel Lymph Node Biopsy
|
N/A | |
Recruiting |
NCT03680833 -
Sentinel Node Detection in Cervical Cancer
|
N/A | |
Completed |
NCT03200704 -
A Study Assessing the Safety and Effectiveness of IC2000 and SPY Fluorescence Imaging Systems (SPY-PHI) in the Visualization of Lymphatic Vessels and Identification of Lymph Nodes During Sentinel Lymph Node Biopsy in Subjects With Breast Cancer
|
Phase 3 | |
Recruiting |
NCT04403867 -
The Role of Micrometastasis and Isolated Tumor Cells (ITCs) in Endometrial and Cervical Cancer. A Multicenter Study.
|
||
Not yet recruiting |
NCT05703295 -
Oncologic Safety of Sentinel Lymph Node Biopsy in Clinically Palpable Axillary Lymph Node in Breast Cancer Patients
|
||
Enrolling by invitation |
NCT05942170 -
The Combination of Preoperative MRI and SLN in the Surgical Management of CC and EC
|
N/A | |
Recruiting |
NCT03937414 -
Intraoperative Molecular Diagnosis of Sentinel Lymph Node In Breast Cancer Patients
|
N/A | |
Recruiting |
NCT06120439 -
Comparing the QoR of PECS Block and GA in Breast-conserving Surgery With Sentinel Lymph Node Biopsy
|
N/A | |
Terminated |
NCT05457842 -
A Study to Find the Best Dose of ASP5354 to Show Lymph Nodes in People With Breast Cancer or Melanoma During Surgery
|
Phase 2 |